Hemab Therapeutics Holdings, Inc.
S-1 FiledCOAG
Hemab Therapeutics Holdings, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Est. valuation
$100M
Exchange
—
Ticker: COAG
Status
S-1 Filed
Filed
Apr 10, 2026
IPO timeline
Apr 10, 2026
S-1 filed with SEC
Initial registration statement submitted to the Securities and Exchange Commission.
Upcoming
Roadshow & pricing
Company presents to institutional investors. IPO price and share count are finalized.
Upcoming
First-day trading
Shares available on the open market.
Frequently asked questions
When is Hemab Therapeutics Holdings, Inc. going public?
Hemab Therapeutics Holdings, Inc. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.
What is Hemab Therapeutics Holdings, Inc.'s IPO valuation?
The estimated offering value is $100M. Final valuation will be determined at pricing.
What exchange will Hemab Therapeutics Holdings, Inc. list on?
No exchange has been officially announced for the Hemab Therapeutics Holdings, Inc. IPO.
Has Hemab Therapeutics Holdings, Inc. filed an S-1 with the SEC?
No. As of the most recent data, Hemab Therapeutics Holdings, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR